Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel (DSG) 1% Applied Four Times Daily in Subjects Experiencing Acute Delayed Onset Muscle Soreness (DOMS) of the Lower Limbs
Conditions
Interventions
Diclofenac sodium gel 1%
Placebo
Locations
1
United States
Lotus Clinical Research, 100 W California Blvd,
Pasadena, California, United States
Start Date
October 1, 2014
Primary Completion Date
December 1, 2014
Completion Date
December 1, 2014
Last Updated
April 5, 2016
NCT06225388
NCT06810271
NCT07438431
NCT05326893
NCT06535906
NCT06612502
Lead Sponsor
Novartis
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions